Gladius Capital Management’s Eli Lilly LLY Stock Holding History

Gladius Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.2M	Buy	25,200 +6,700	+36%	+$6.79M	1.03%	23
2025 Q4	$19.9M	Buy	18,500 +11,400	+161%	+$10.9M	1.09%	24
2025 Q3	$5.42M	Buy	+7,100	New	+$5.28M	0.57%	41
2024 Q1	–	Sell	-4,300	Closed	-$2.51M	–	370
2023 Q4	$2.51M	Sell	4,300 -8,500	-66%	-$4.96M	0.39%	57
2023 Q3	$6.88M	Buy	12,800 +4,600	+56%	+$2.37M	0.29%	69
2023 Q2	$3.85M	Buy	8,200 +2,000	+32%	+$839K	0.19%	56
2023 Q1	$2.13M	Buy	+6,200	New	+$2.09M	0.12%	83

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gladius Capital Management's LLY Position: Q1 2026 in Review

Gladius Capital Management opened a new position in Eli Lilly (LLY) in Q1 2026: 3,400 shares worth $3.13M. The stake represents 0.14% of the portfolio and ranks #81 among its holdings. This is a return to the name: Gladius Capital Management previously reported a position in LLY as recently as Q3 2025.

Gladius Capital Management first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. The position peaked at $6.09M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Gladius Capital Management held 3,400 shares of Eli Lilly worth $3.13M as of Q1 2026.
Eli Lilly was a new Gladius Capital Management position in Q1 2026.
Eli Lilly made up 0.14% of Gladius Capital Management's portfolio in Q1 2026, its #81 holding.
Gladius Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
Gladius Capital Management's Eli Lilly position peaked at $6.09M in Q4 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.